1. Action plan for the health sector response to HIV in the WHO European Region. In. Copenhagen: World Health Organization Regional Office for Europe (2016). https://www.euro.who.int/__data/assets/pdf_file/0010/315649/66wd09e_HIVActionPlan_160560.pdf (Last accessed on 13.09.2022)
2. Marcus U (2019) HIV infections and HIV testing during pregnancy, Germany, 1993 to 2016. Euro Surveill. https://doi.org/10.2807/1560-7917.ES.2019.24.48.1900078
3. Richtlinien des Gemeinsamen Bundesausschusses über die ärztliche Betreuung während der Schwangerschaft und nach der Entbindung („Mutterschafts-Richtlinien“) In: Bundesanzeiger (1985). https://www.g-ba.de/downloads/62-492-2676/Mu-RL_2021-09-16_iK-2022-01-01.pdf (Last accessed on 13.09.2022)
4. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT (2011) Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003510.pub3
5. Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Transmission in the United States. In: HHS Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission - A Working Group of the Office of AIDS Research Advisory Council (OARAC) (2021). https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Perinatal_GL.pdf (Last accessed on 13.09.2022)